# GADOTERATE MEGLUMINE
> **ANDA215304** · Abbreviated New Drug Application (Generic) · Sponsor: HENGRUI PHARMA · Approved 2022-04-11
## Drug
- **FDA Application Number:** ANDA215304
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** GADOTERATE MEGLUMINE
- **Generic name:** GADOTERATE MEGLUMINE
- **Active ingredients:** GADOTERATE MEGLUMINE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Discontinued
- **Sponsor:** HENGRUI PHARMA
- **Manufacturer:** Fresenius Kabi USA, LLC
- **First approval:** 2022-04-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215304)
---
*MORVS · CC0 1.0*